These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mutations of transcription factors in human with heart disease for understanding the development and mechanisms of congenital cardiovascular heart disease. Matsuoka R Adv Exp Med Biol; 2005; 565():349-57; discussion 405-15. PubMed ID: 16106988 [No Abstract] [Full Text] [Related]
3. Complex story of the genetic origins of pediatric heart disease. Benson DW; Martin LJ Circulation; 2010 Mar; 121(11):1277-9. PubMed ID: 20212285 [No Abstract] [Full Text] [Related]
4. [Progress in studies on somatic mutations in congenital heart disease]. Yin J; Yang SW; Qin YM Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):634-5. PubMed ID: 23158746 [No Abstract] [Full Text] [Related]
5. Elucidating the molecular and genetic interactions responsible for congenital heart disease. Jay PY; Izumo S Pediatr Res; 2002 Feb; 51(2):127. PubMed ID: 11809903 [No Abstract] [Full Text] [Related]
6. Single allele mutations at the heart of congenital disease. Rosenthal N; Harvey RP J Clin Invest; 1999 Dec; 104(11):1483-4. PubMed ID: 10587507 [No Abstract] [Full Text] [Related]
12. Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Pashmforoush M; Lu JT; Chen H; Amand TS; Kondo R; Pradervand S; Evans SM; Clark B; Feramisco JR; Giles W; Ho SY; Benson DW; Silberbach M; Shou W; Chien KR Cell; 2004 Apr; 117(3):373-86. PubMed ID: 15109497 [TBL] [Abstract][Full Text] [Related]
13. Ventricular noncompaction and distal chromosome 5q deletion. Pauli RM; Scheib-Wixted S; Cripe L; Izumo S; Sekhon GS Am J Med Genet; 1999 Aug; 85(4):419-23. PubMed ID: 10398271 [TBL] [Abstract][Full Text] [Related]
14. A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Moskowitz IP; Kim JB; Moore ML; Wolf CM; Peterson MA; Shendure J; Nobrega MA; Yokota Y; Berul C; Izumo S; Seidman JG; Seidman CE Cell; 2007 Jun; 129(7):1365-76. PubMed ID: 17604724 [TBL] [Abstract][Full Text] [Related]
15. [Preliminary exploration of transcription factor Nkx2.5 mutations and congenital heart diseases]. Ding JD; Li KR; Zhang XL; Yao YY; Reng LQ; Tao SY; Fang X; Ma GS Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(16):1114-6. PubMed ID: 19595143 [TBL] [Abstract][Full Text] [Related]
16. Homeodomain factor Nkx2-5 in heart development and disease. Harvey RP; Lai D; Elliott D; Biben C; Solloway M; Prall O; Stennard F; Schindeler A; Groves N; Lavulo L; Hyun C; Yeoh T; Costa M; Furtado M; Kirk E Cold Spring Harb Symp Quant Biol; 2002; 67():107-14. PubMed ID: 12858530 [No Abstract] [Full Text] [Related]
17. Molecular mechanisms of ventricular hypoplasia. Srivastava D; Gottlieb PD; Olson EN Cold Spring Harb Symp Quant Biol; 2002; 67():121-5. PubMed ID: 12858532 [TBL] [Abstract][Full Text] [Related]
18. Cardiac expression of the ventricle-specific homeobox gene Irx4 is modulated by Nkx2-5 and dHand. Bruneau BG; Bao ZZ; Tanaka M; Schott JJ; Izumo S; Cepko CL; Seidman JG; Seidman CE Dev Biol; 2000 Jan; 217(2):266-77. PubMed ID: 10625552 [TBL] [Abstract][Full Text] [Related]
19. NKX2.5 and congenital heart defects: A population-based study. Hobbs CA; Cleves MA; Keith C; Ghaffar S; James SJ Am J Med Genet A; 2005 Apr; 134A(2):223-5. PubMed ID: 15633194 [No Abstract] [Full Text] [Related]
20. Recent advances in cardiac development with therapeutic implications for adult cardiovascular disease. Epstein JA; Parmacek MS Circulation; 2005 Jul; 112(4):592-7. PubMed ID: 16043659 [No Abstract] [Full Text] [Related] [Next] [New Search]